Home › Cancer (all types) › Arizona
Cancer (all types) clinical trials in Arizona
53 studies for Cancer (all types) are looking for participants at sites in Arizona.
Cities in Arizona
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic Arizona /ID# 251405, Phoenix
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Arizona, Tucson
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Cancer Center at Saint Joseph's, Phoenix
- Mayo Clinic Hospital in Arizona, Phoenix
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- HonorHealth Scottsdale Osborn Medical Center, Scottsdale
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope Phoenix, Goodyear
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Banner MD Anderson Cancer Center, Gilbert
- Banner University Medical Center Phoenix, Phoenix
- The University of Arizona Cancer Center - North Campus, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Banner MD Anderson Cancer Center, Gilbert
- Mayo Clinic Phoenix, Phoenix
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
- Honor Health, Scottsdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06959706Multi-Cancer Detection Observational Cohort Study
- Mayo Clinic in Arizona, Scottsdale
RecruitingObservational studyHealthy volunteers welcome
Ages 21 and older · All sexes · Updated Oct 26, 2026 · NCT06962995Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
- Mayo Clinic in Arizona, Scottsdale
Recruiting
Ages 15 and older · All sexes · Updated Oct 26, 2026 · NCT07856394Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Banner Health, Gilbert
- Mayo Clinic Hospital, Phoenix
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Banner MD Anderson Cancer Center, Gilbert
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06162221INTERogating Cancer for Etiology, Prevention and Therapy Navigation
- Mayo Clinic in Arizona, Scottsdale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06008392A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Hospital, Phoenix
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT06989437A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
- East Valley Urology Center of Arizona, Queen Creek
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07725796FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- St. Joseph's Hospital and Medical Center, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT03328078Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- East Valley Urology Center of Arizona, Queen Creek
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT07480356A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Ironwood Cancer and Research Centers - Chandler /ID# 275443, Chandler
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07005102Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
- Mayo Clinic in Arizona, Scottsdale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06880861Registry Study for Radiation Therapy Outcomes
- Mayo Clinic, Scottsdale
RecruitingObservational study
All ages · All sexes · Updated Sep 29, 2026 · NCT01255748A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City Of Hope - Phoenix /ID# 281323, Goodyear
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Cancer Treatment Centers of America-Phoenix, Phoenix
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Mayo Clinic Arizona, Phoenix
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Mayo Clinic Phoenix, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Ironwood Cancer and Research Centers Scottsdale, Chandler
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06252649Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
- University of Arizona-Cancer Center, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Mayo Clinic Arizona, Phoenix
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07321106ORB-021 In Patients With Advanced Solid Tumors
- Honor Health Clinical Research, Scottsdale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06607939Project: Every Child for Younger Patients With Cancer
- Kingman Regional Medical Center, Kingman
- Banner Children's at Desert, Mesa
- Phoenix Childrens Hospital, Phoenix
- and 1 more
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Phoenix Children's Hospital, Phoenix
- Phoenix Children's Hospital, Phoenix
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Aug 7, 2026 · NCT05999994Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
- University of Arizona Cancer Center, Tucson
Recruiting
Ages 18 and older · All sexes · Updated Jul 20, 2026 · NCT07415564Molecular Genetics Studies of Cancer Patients and Their Relatives
- Valleywise Comprehensive Health Center - Phoenix, Phoenix
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jun 29, 2026 · NCT04185935Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
- University of Arizona Cancer Center, Tucson
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07407582Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Southern Arizona VA Health Care System, Tucson, AZ, Tucson
Recruiting
Ages 18 to 75 · All sexes · Updated Jun 17, 2026 · NCT05486572A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Banner Health, Gilbert
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- University of Arizona Cancer Center - Tucson /ID# 262698, Tucson
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT04777994Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
- Pioneer Research Center, LLC, Bullhead City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT06463665I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Mayo Clinic - Scottsdale, Scottsdale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- University of Arizona Cancer Center, Tucson
Recruiting
Ages 18 to 80 · All sexes · Updated Apr 30, 2026 · NCT06644560From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.